New Position Paper on BRONJ from the AAOMS

AAOMS Position Paper on BRONJThe American Association of Oral and Maxillofacial Surgeons (AAOMS) has released a Position Paper recommending the change in the nomenclature of “bisphosphonate-related osteonecrosis of the jaw (BRONJ)” to the more accurate term “medication-related osteonecrosis of the jaw (MRONJ)” and provided recommendations regarding risk/benefit analysis of medications and treatment guidance to clinicians.

The stated purpose of this updated position paper is to provide: risk estimates of developing MRONJ, comparisons of the risks and benefits of medications related to osteonecrosis of the jaw (ONJ) in order to facilitate medical decision-making for the treating physician, dentist, dental specialist, and patients. Additionally the paper will provide guidance to surgeons regarding: the differential diagnosis of MRONJ in patients with a history of exposure to antiresorptive and/or antiangiogenic agents and MRONJ prevention measures and management strategies for patients with MRONJ based on the disease stage.

Download the Position Paper

How many teeth are involved in the crown lengthening procedure?
3D Imaging Technology Can Enhance Patient Care